Third-generation neuroimaging in early schizophrenia: Translating research evidence into clinical utility

British Journal of Psychiatry

Volumn 200, Issue 4, 2012, Pages 270-272

  Borgwardt, Stefan ^a,b   Fusar Poli, Paolo ^b  

^a UNIVERSITY OF BASEL   (Switzerland)

^b KING'S COLLEGE LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

NEUROLEPTIC AGENT;

CINGULATE GYRUS; COMPUTER ASSISTED TOMOGRAPHY; DIFFUSION TENSOR IMAGING; DOPAMINE METABOLISM; DOPAMINERGIC TRANSMISSION; FOLLOW UP; FUNCTIONAL MAGNETIC RESONANCE IMAGING; GENE SEQUENCE; HIPPOCAMPUS; HUMAN; INSULA; LIPIDOMICS; META ANALYSIS (TOPIC); MULTICENTER STUDY (TOPIC); NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; OUTCOME ASSESSMENT; PARAHIPPOCAMPAL GYRUS; POSITRON EMISSION TOMOGRAPHY; PREFRONTAL CORTEX; PROTEOMICS; REMISSION; REVIEW; SCHIZOPHRENIA; SUPPORT VECTOR MACHINE; SYSTEMATIC REVIEW (TOPIC); TEMPORAL LOBE; TRACTOGRAPHY; VOXEL BASED MORPHOMETRY;

FEMALE; HUMANS; MALE; MEMORY; MEMORY DISORDERS; SCHIZOPHRENIA;

EID: 84859612395     PISSN: 00071250     EISSN: 14721465     Source Type: Journal    
DOI: 10.1192/bjp.bp.111.103234     Document Type: Review

References (26)

1. Bodnar M, Achim AM, Malla AK, Joober R, Benoit A, Lepage M. Functional magnetic resonance imaging correlates of memory encoding in relation to achieving remission in first-episode schizophrenia. Br J Psychiatry 2012; 200: 300-7.
2. Weinberger DR, DeLisi LE, Neophytides AN, Wyatt RJ. Familial aspects of CT scan abnormalities in chronic schizophrenic patients. Psychiatry Res 1981; 4: 65-71. (Pubitemid 11131778)
3. Kishimoto H, Kuwahara H, Ohno S, Takazu O, Hama Y, Sato C, et al. Three subtypes of chronic schizophrenia identified using 11C-glucose positron emission tomography. Psychiatry Res 1987; 21: 285-92. (Pubitemid 17138576)
4. Johnstone EC, Crow TJ, Frith CD, Husband J, Kreel L. Cerebral ventricular size and cognitive impairment in chronic schizophrenia. Lancet 1976; 2: 924-6.
5. Bora E, Fornito A, Radua J, Walterfang M, Seal M, Wood SJ, et al. Neuroanatomical abnormalities in schizophrenia: a multimodal voxelwise meta-analysis and meta-regression analysis. Schizophr Res 2011; 127: 46-57.
6. Lahti AC, Weiler MA, Holcomb HH, Tamminga CA, Cropsey KL. Modulation of limbic circuitry predicts treatment response to antipsychotic medication: a functional imaging study in schizophrenia. Neuropsychopharmacology 2009; 34: 2675-90.
7. Snitz BE, Macdonald A 3rd, Cohen JD, Cho RY, Becker T, Carter CS. Lateral and medial hypofrontality in first-episode schizophrenia: functional activity in a medication-naive state and effects of short-term atypical antipsychotic treatment. Am J Psychiatry 2005; 162: 2322-9. (Pubitemid 41740211)
8. Smieskova R, Fusar-Poli P, Allen P, Bendfeldt K, Stieglitz RD, Drewe J, et al. The effects of antipsychotics on the brain: what have we learnt from structural imaging of schizophrenia? A systematic review. Curr Pharm Des 2009; 15: 2535-49.
9. Fusar-Poli P, Radua J, McGuire P, Borgwardt S. Neuroanatomical maps of psychosis onset: voxel-wise meta-analysis of antipsychotic-naive VBM studies. Schizophr Bull 2011; Nov 10 (Epub ahead of print).
10. Fusar-Poli P, Bonoldi I, Yung AR, Borgwardt S, Kempton M, Barale F, et al. Predicting psychosis: meta-analysis of transition outcomes in individuals at high risk. Arch Gen Psychiatry 2012, in press.
11. Fusar-Poli P, Borgwardt S, Crescini A, Deste G, Kempton MJ, Lawrie S, et al. Neuroanatomy of vulnerability to psychosis: a voxel-based meta-analysis. Neurosci Biobehav Rev 2011; 35: 1175-85.
12. Smieskova R, Fusar-Poli P, Allen P, Bendfeldt K, Stieglitz R, Drewe J, et al. Neuroimaging predictors of transition to psychosis - a systematic review and meta-analysis. Neurosci Biobehav Rev 2010; 34: 1207-22.
13. Ettinger U, Williams SC, Meisenzahl EM, Moller HJ, Kumari V, Koutsouleris N. Association between brain structure and psychometric schizotypy in healthy individuals. World J Biol Psychiatry 2011; Oct 24 (Epub ahead of print).
14. Simon AE, Velthorst E, Nieman DH, Linszen D, Umbricht D, de Haan L. Ultra high-risk state for psychosis and non-transition: a systematic review. Schizophr Res 2011; 132: 8-17.
15. Addington J, Cornblatt BA, Cadenhead KS, Cannon TD, McGlashan TH, Perkins DO, et al. At clinical high risk for psychosis: outcome for nonconverters. Am J Psychiatry 2011; 168: 800-5.
16. Smieskova R, Allen P, Simon A, Aston J, Bendfeldt K, Drewe J, et al. Different duration of at-risk mental state associated with neurofunctional abnormalities. A multimodal imaging study. Hum Brain Mapp 2011; Sept 16 (Epub ahead of print).
17. Stone J, Day F, Tsagaraki H, Valli I, McLean M, Lythgoe D, et al. Glutamate dysfunction in people with prodromal symptoms of psychosis: relationship to gray matter volume. Mol Psychiatry 2009; 66: 533-9.
18. Howes O, Bose S, Turkheimer F, Valli I, Egerton A, Stahl D, et al. Progressive increase in striatal dopamine synthesis capacity as patients develop psychosis: a PET study. Mol Psychiatry 2011; 16: 885-6.
19. Fusar-Poli P, Meyer-Lindenberg A. Striatal presynaptic dopamine in schizophrenia, part II: meta-analysis of [18F]/[11C] DOPA PET studies. Schizophr Bull 2012; Jan 26 (Epub ahead of print).
20. Ruhrmann S, Schultze-Lutter F, Bechdolf A, Klosterkotter J. Intervention in at-risk states for developing psychosis. Eur Arch Psychiatry Clin Neurosci 2010; 260 (suppl 2): s90-4.
21. Fusar-Poli P, Howes OD, Allen P, Broome M, Valli I, Asselin MC, et al. Abnormal frontostriatal interactions in people with prodromal signs of psychosis: a multimodal imaging study. Arch Gen Psychiatry 2010; 67: 683-91.
22. Mechelli A, Riecher-Rossler A, Meisenzahl EM, Tognin S, Wood SJ, Borgwardt SJ, et al. Neuroanatomical abnormalities that predate the onset of psychosis: a multicenter study. Arch Gen Psychiatry 2011; 68: 489-95.
23. Orrù G, Pettersson-Yeo W, Marquand AF, Sartori G, Mechelli A. Using Support Vector Machine to identify imaging biomarkers of neurological and psychiatric disease: a critical review. Neurosci Biobehav Rev 2012; 36: 1140-52.
24. Koutsouleris N, Borgwardt S, Meisenzahl EM, Bottlender R, Moller HJ, Riecher-Rossler A. Disease prediction in the at-risk mental state for psychosis using neuroanatomical biomarkers: results from the FePsy study. Schizophr Bull 2011; Nov 10 (Epub ahead of print).
25. Meyer-Lindenberg A. The future of fMRI and genetics research. NeuroImage 2011; Oct 28 (Epub ahead of print).
26. Fusar-Poli P, Borgwardt S, McGuire P. Vulnerability to Psychosis: From Neurosciences to Psychopathology. Psychology Press, 2011.